WO2003081234A3 - Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) - Google Patents
Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) Download PDFInfo
- Publication number
- WO2003081234A3 WO2003081234A3 PCT/EP2003/002687 EP0302687W WO03081234A3 WO 2003081234 A3 WO2003081234 A3 WO 2003081234A3 EP 0302687 W EP0302687 W EP 0302687W WO 03081234 A3 WO03081234 A3 WO 03081234A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gpr8
- therapeutics
- diagnostics
- protein
- homo sapiens
- Prior art date
Links
- 101000603411 Homo sapiens Neuropeptides B/W receptor type 2 Proteins 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 2
- 102100038843 Neuropeptides B/W receptor type 2 Human genes 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000055497 human NPBWR2 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003212356A AU2003212356A1 (en) | 2002-03-26 | 2003-03-14 | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02006650 | 2002-03-26 | ||
EP02006650.2 | 2002-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003081234A2 WO2003081234A2 (en) | 2003-10-02 |
WO2003081234A3 true WO2003081234A3 (en) | 2004-02-05 |
Family
ID=28051730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/002687 WO2003081234A2 (en) | 2002-03-26 | 2003-03-14 | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003212356A1 (en) |
WO (1) | WO2003081234A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1602380A4 (en) * | 2003-03-13 | 2009-09-02 | Takeda Chemical Industries Ltd | Preventive/remedy for diseases in upper digestive tract |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070971A2 (en) * | 2000-03-24 | 2001-09-27 | Bayer Aktiengesellschaft | Regulation of human mas oncogene-related g protein-coupled receptor |
WO2001098494A1 (en) * | 2000-06-21 | 2001-12-27 | Takeda Chemical Industries, Ltd | Ligand to gpr8 and dna thereof |
-
2003
- 2003-03-14 AU AU2003212356A patent/AU2003212356A1/en not_active Abandoned
- 2003-03-14 WO PCT/EP2003/002687 patent/WO2003081234A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070971A2 (en) * | 2000-03-24 | 2001-09-27 | Bayer Aktiengesellschaft | Regulation of human mas oncogene-related g protein-coupled receptor |
WO2001098494A1 (en) * | 2000-06-21 | 2001-12-27 | Takeda Chemical Industries, Ltd | Ligand to gpr8 and dna thereof |
EP1293567A1 (en) * | 2000-06-21 | 2003-03-19 | Takeda Chemical Industries, Ltd. | Ligand to gpr8 and dna thereof |
Non-Patent Citations (2)
Title |
---|
KEITOKU MITSUMASA ET AL: "FMLP actions and its binding sites in isolated human coronary arteries.", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, vol. 29, no. 3, 1997, pages 881 - 894, XP002249990, ISSN: 0022-2828 * |
PADIGARU MURALIDHARA ET AL: "Novel G-protein-coupled receptors: Structure and tissue expression analysis.", INTERNATIONAL GENOME SEQUENCING AND ANALYSIS CONFERENCE, vol. 12, 2000, 12th International Genome Sequencing and Analysis Conference;Miami Beach, Florida, USA; September 12-15, 2000, pages 82, XP001162842 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003081234A2 (en) | 2003-10-02 |
AU2003212356A1 (en) | 2003-10-08 |
AU2003212356A8 (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003081258A3 (en) | Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) | |
WO2003074069A3 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
WO2004008153A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr) | |
WO2004099782A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) | |
WO2003081234A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) | |
WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
WO2004082570A3 (en) | Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2) | |
WO2003080097A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) | |
WO2004038405A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
WO2003065044A8 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
WO2004099783A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) | |
WO2003080100A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63) | |
WO2003096020A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
WO2003080098A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2 | |
WO2003066077A3 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
WO2004086034A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a3(adora3) | |
WO2004038421A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
WO2004086047A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a1 (adora1) | |
WO2004015422A3 (en) | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) | |
WO2004106935A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) | |
WO2004048978A3 (en) | Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) | |
WO2004038416A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
WO2003076945A3 (en) | Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) | |
WO2004015427A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |